Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Clinical trial NCT01269437 · UNKNOWN
Trial details
- NCT number
- NCT01269437
- Sponsor
- NovaMed Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-10-01
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.